Fol. Biol. 2002, 48, 167-181
Immunotherapeutic Approaches for Renal Cancer
Renal carcinoma is no doubt one of the strangest urologic tumours. Its multifaceted symptoms can defy the most perceptive physician, for more often than not the symptoms do not suggest a renal pathology. Its frequency and mortality are not negligible. In the United States, there are 27 600 new cases of renal cell carcinoma each year, and 1 300 die from this cancer. Indeed, 30% of the patients have already developed metastases at the time of the initial diagnosis or at the time of the first relapse. Considering the resistance to chemotherapy and/or radiotherapy of this tumour, the prognosis remains bleak.
Keywords
cancer, immunotherapy, interferon, interleukin, intra-lymphatic, kidney, LAK, renal carcinoma, transfer factor.
References
Copyright
This is an open-access article distributed under the terms of the Creative Commons Attribution License.